GM-CSF Reporter HEK 293 Cells

STAT5-SEAP reporter cells

ABOUT

GM-CSF responsive STAT5-SEAP reporter assay

HEK-Blue™ GM-CSF cells are designed to monitor human GM-CSF-induced STAT5 stimulation or inhibition through SEAP detection. This colorimetric bioassay can be used for screening activatory molecules, such as engineered cytokines, or inhibitory molecules, such as neutralizing antibodies.

HEK-Blue™ GM-CSF cells respond specifically to recombinant human GM-CSF. The reliable and consistent performance of HEK-Blue™ GM-CSF cells makes them suitable for release assays of therapeutic molecules that inhibit GM-CSF signaling, such as Mavrilimumab , a monoclonal antibody targeting the α chain of GM-CSF receptor (see figures).

Key features

  • Readily assessable STAT5-SEAP reporter activity
  • Convenient readout using QUANTI-Blue™ Solution
  • High sensitivity to human (h) GM-CSF activity
  • Stability guaranteed for 20 passages

Applications

  • Therapeutic development
  • Drug screening
  • Release assay

 

Granulocyte-macrophage colony-stimulating factor (GM-CSF, aka CSF2), although originally identified as a hematopoietic growth factor, is now regarded as a pleiotropic regulator of inflammation in the responses to pathogens, autoimmune diseases, and cancer [1, 2].

more details More details

Disclaimer:  These cells are for internal research use only and are covered by a Limited Use License (See Terms and Conditions). Additional rights may be available.

SPECIFICATIONS

Specifications

Tested applications

Detection and quantification of GM-CSF activity

Cell type
Epithelial
Growth properties
Adherent
Tissue origin
Human embryonic kidney cells
Reporter gene
SEAP
Detection method
Colormetric
Detection range

Human GM-CSF: 5 pg/ml - 100 ng/ml

Antibiotic resistance
Blasticidin
Hygromycin
Zeocin®
Growth medium

Complete DMEM (see TDS)

Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    HEK-Blue™ GM-CSF Cells
  • Cat code: 
    hkb-hgmcsfr
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 2 x 1 ml HEK-Blue Selection (250X concentrate)
  • 1 ml Normocin® (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

Cell line description

HEK-Blue™ GM-CSF cells were generated by stable transfection with the genes encoding for human GMRα (CD116), GMRβ (CD131), STAT5, as well as a STAT5-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. The binding of GM-CSF to its receptor triggers a signaling cascade leading to the activation of STAT5 and the subsequent production of SEAP. This can be readily assessed in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent.

HEK-Blue™ GM-CSF cells strongly respond to human, but not mouse, GM-CSF. Of note, these cells are not responsive to human IL-6, IL-27, and type I IFN (see figures).

 

GM-CSF background

The granulocyte-macrophage colony-stimulating factor (GM-CSF, aka CSF2) belongs to the β-common chain cytokine family [1]. Although originally identified as a hematopoietic growth factor, this cytokine is now regarded as a pleiotropic regulator of inflammation in the responses to pathogens, autoimmune diseases, and cancer [1, 2]. GM-CSF signalization requires a multimeric structure comprising four α chains (GMRα, aka CD116), four β chains (GMRβ aka CD131), and four cytokines. This 12-protein complex allows the juxtaposition of the intracellular Janus kinase 2 (JAK2) and activation of the signal transducer and activator of transcription 5 (STAT5) [1]. Other signaling pathways include ERK, NF-κB, and AKT pathways [2, 3]. 

The understanding of cellular and molecular mechanisms whereby GM-CSF exerts its varied functions is key for the development of therapeutic strategies (e.g. cancer vaccines, blocking antibodies) [1]. 

 

1. Dougan M. et al., 2019. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 50(4):796-811.
2. Zhan Y. et al., 2019. The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game. Front Immunol. 102679.
3. Hamilton J.A., 2020. GM-CSF in inflammation. J. Exp . Med. 217(1):e20190945.

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?